why choose us

First received: June 08, 2023

Clinical Trial: CO2 Rebreathing in nOH: A Proof-of-Concept Pilot Study

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Neurogenic Orthostatic Hypotension

Study Type: INTERVENTIONAL


Official Title: CO2 Rebreathing to Increase Blood Pressure in Neurogenic Orthostatic Hypotension: A Proof-of-Concept Pilot Study

Brief Summary: Neurogenic orthostatic hypotension (nOH) is a chronic condition associated with increased cardiovascular risk and reduced quality of life.On standing, patients with nOH experience a large reduction in blood pressure (BP; at least ?20/10mmHg, but often much more), which is often accompanied by debilitating symptoms and syncope.A previous study (unpublished) showed that hypercapnia significantly increases standing BP in patients with nOH.Human bodies naturally produce and exhale CO2.Rebreathe devices offer a…

Read more